Cargando…
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
BACKGROUND: Epigenetic changes play a key role in the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor. METHODS: We explore the therapeutic potential of BMI1 and MAPK/ERK inhibition in BMI1(High);CHD7(Low) MB cells and in a preclinical xenograft model. RESULTS: W...
Autores principales: | Badodi, Sara, Pomella, Nicola, Lim, Yau Mun, Brandner, Sebastian, Morrison, Gillian, Pollard, Steven M, Zhang, Xinyu, Zabet, Nicolae Radu, Marino, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340634/ https://www.ncbi.nlm.nih.gov/pubmed/35213723 http://dx.doi.org/10.1093/neuonc/noac052 |
Ejemplares similares
-
MEDB-23. Targeting epigenetic dysregulation in medulloblastoma with poor prognosis
por: Badodi, Sara, et al.
Publicado: (2022) -
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation
por: Badodi, Sara, et al.
Publicado: (2021) -
EMBR-10. INOSITOL TREATMENT INHIBITS MEDULLOBLASTOMA THROUGH SUPPRESSION OF EPIGENETIC-DRIVEN METABOLIC ADAPTATION
por: Badodi, Sara, et al.
Publicado: (2021) -
Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma
por: Badodi, Sara, et al.
Publicado: (2017) -
Characterization of G-CSF receptor expression in medulloblastoma
por: Paul, Megan Rose, et al.
Publicado: (2020)